NurExone advances optic nerve program toward larger-animal study
NurExone says preclinical results at Sheba Medical Center showed retinal recovery using its exosome-based lead candidate NurExone, and the program is moving toward larger-animal study.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.